Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 26, 2009

View Archived Issues

Karo Bio present update on drug development programs

Dienogest exhibits favorable safety profile in the long-term treatment of endometriosis

Phase I study results encourage further development of anesthetic PF-0713

EMEA committee informs Antigenics of negative opinion on MAA for Oncophage in RCC

Gilead reports results from third quarter of 2009

PSN-0041 displays enhanced antidepressant activity over native amylin in preclinical tests

Preclinical characterization of SEP-230864 presented by Sepracor

KB-099520 increases serotonergic activity and demonstrates antidepressant effects

IMO-3100 active in arthritis model, intended for clinical development

Naproxcinod efficacy similar to naproxen in knee osteoarthritis patients

Brain autoimmune mechanisms implicated in the pathogenesis of OCD / News in Context

Peregrine reports positive tumor response rate in phase II bavituximab trial

Aerie reports phase IIa results for ROCK inhibitor, AR-12286, in glaucoma

AcelRx presents results from phase II ARX-03 study

KemPharm commences phase I KP-106 trial in ADHD

Roche doses first patient in phase III subcutaneous Herceptin trial

TargeGen completes TG-101348 trial in patients with myelofibrosis

NexGenix awarded phase I grant for small-molecule Hsp90 compounds for glioma

Repligen licenses compounds for potential spinal muscular atrophy treatment

Merck and Schering-Plough receive European Commission clearance for merger

Aeolus drug protects gastrointestinal tract in acute radiation syndrome studies

CHMP recommends Boehringer's Micardis for CV morbidity in high CV risk patients

Onyx and Bayer initiate phase III trial of Nexavar in nonresponsive thyroid cancer

Pharmaxis commences pivotal bronchiectasis study with Bronchitol

CGRP antagonists for the treatment of migraine claimed by Merck & Co.

New glucokinase activators described by Astellas Pharma as antidiabetic agents

GlaxoSmithKline presents antiviral compounds for HCV infection

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
Neutrophils put the brakes on fat loss
BioWorld Science
Fat tissue balances energy by storing lipids during times of abundance and mobilizing them when needed, yet sustained metabolic stress demands mechanisms that...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Peptidream reveals milestone in Alnylam collaboration
BioWorld Science
Peptidream Inc. has announced a preclinical development milestone in its collaboration with Alnylam Pharmaceuticals Inc. under their siRNA conjugate discovery...